title: Reply to G. Spitzer and M.A. Socinski, F. Zhou et al, and B. Biswas.
authors.affiliation: Osaka City University and National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan kawaguchi.tomoya@med.osaka-cu.ac.jp.
authors.forename: Tomoya
authors.initials: T
authors.lastname: Kawaguchi
authors.affiliation: Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Aichi, Japan.
authors.forename: Masahiko
authors.initials: M
authors.lastname: Ando
authors.affiliation: Aichi Medical University School of Medicine and National Hospital Organization Nagoya Medical Center, Aichi, Japan.
authors.forename: Akihito
authors.initials: A
authors.lastname: Kubo
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D010166:Palliative Care / Q000379:methods*; D011799:Quinazolines / Q000627:therapeutic use*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011799:Quinazolines; D043823:Taxoids